Frankfurt, Germany

Sabine Haag-Richter

This inventor holds 5 USPTO granted patents and 1 EPO patent. Top assignees: Sanofi-A Ventis Deutschland Gmbh, Aventis Pharma Deutschland, Gmbh, Aventis Pharmaceuticals Inc.. Active years: 2005-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sabine Haag-Richter. Retrieved from https://idiyas.com/inventor/sabine-haag-richter

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 20.0


Average Co-Inventor Count = 2.2

ph-index = 2

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2005-2009

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Sabine Haag-Richter: Innovator in Cancer Treatment

Introduction

Sabine Haag-Richter is a prominent inventor based in Frankfurt-am-Main, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of bengamide derivatives for cancer treatment. With a total of five patents to her name, her work has the potential to impact the medical community significantly.

Latest Patents

Her latest patents focus on bengamide derivatives, which are formed during fermentation by the microorganism ST200611 (DSM 15898). These derivatives are aimed at treating cancer diseases and are incorporated into pharmaceuticals. The patents also detail a process for preparing bengamides of a specific formula and highlight the microorganism involved in their production.

Career Highlights

Sabine has worked with notable companies such as Sanofi-Aventis Deutschland GmbH and Aventis Pharma Deutschland GmbH. Her experience in these organizations has allowed her to develop her innovative ideas and bring them to fruition.

Collaborations

Throughout her career, Sabine has collaborated with professionals like Holger Hoffmann and Michael Kurz. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Sabine Haag-Richter is a trailblazer in the field of cancer treatment innovations. Her work with bengamide derivatives showcases her commitment to improving healthcare through scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…